Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy

Small

Volumn 10, Issue 3, 2014, Pages 566-575

  Ansari, Celina ^a   Tikhomirov, Grigory A ^a   Hong, Su Hyun ^a   Falconer, Robert A ^b   Loadman, Paul M ^b   Gill, Jason H ^c   Castaneda, Rosalinda ^a   Hazard, Florette K ^a   Tong, Ling ^a   Lenkov, Olga D ^a   Felsher, Dean W ^a   Rao, Jianghong ^a   Daldrup Link, Heike E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

cancer therapy; iron oxide; MMP 14; MR imaging; nanoparticles; theranostic

Indexed keywords

CANCER THERAPY; INTRAVENOUS ADMINISTRATION; IRON OXIDE NANOPARTICLE; MATRIX METALLOPROTEINASES; MMP-14; MR IMAGING; TARGETED CANCER THERAPY; THERANOSTIC;

CELL CULTURE; CELL DEATH; DRUG DELIVERY; ENZYMES; HISTOLOGY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; ONCOLOGY; TOXICITY; TUMORS;

SYNTHESIS (CHEMICAL);

ANTINEOPLASTIC AGENT; CASPASE; DIAGNOSTIC AGENT; IRON OXIDE; MATRIX METALLOPROTEINASE; NANOPARTICLE;

ANIMAL; ARTICLE; CANCER THERAPY; DRUG EFFECT; ENZYMOLOGY; FEMALE; FIBROBLAST; HUMAN; METABOLISM; MMP-14; MOUSE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSICAL CHEMISTRY; THERANOSTIC;

CANCER THERAPY; IRON OXIDE; MMP-14; MR IMAGING; NANOPARTICLES; THERANOSTIC;

ANIMALS; ANTINEOPLASTIC AGENTS; CASPASES; FEMALE; FIBROBLASTS; HUMANS; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MICE; NANOPARTICLES; NEOPLASMS; PHYSICOCHEMICAL PHENOMENA;

EID: 84893463349     PISSN: 16136810     EISSN: 16136829     Source Type: Journal    
DOI: 10.1002/smll.201301456     Document Type: Article

References (52)

1. a) S. Mura, P. Couvreur, Adv. Drug Delivery Rev. 2012, 64, 1394-1416
2. b) R. K. Jain, T. Stylianopoulos, Nat. Rev. Clin. Oncol. 2010, 7, 653-664
3. c) T. Lammers, F. Kiessling, W. E. Hennink, G. Storm, J. Controlled Release 2012, 161, 175-187
4. d) E. Terreno, F. Uggeri, S. Aime, J. Controlled Release 2012, 161, 328-337.
5. K. Greish, in Cancer Nanotechnology: Methods and Protocols, Vol. 624 (Ed.:, M. Grobmyer,), 2010, pp. 25-37.
6. F. Marcucci, F. Lefoulon, Drug Discov. Today 2004, 9, 219-228.
7. a) G. M. Tozer, V. E. Prise, J. Wilson, M. Cemazar, S. Q. Shan, M. W. Dewhirst, P. R. Barber, B. Vojnovic, D. J. Chaplin, Cancer Res. 2001, 61, 6413-6422
8. b) G. M. Tozer, C. Kanthou, B. C. Baguley, Nat. Rev. Cancer 2005, 5, 423-435.
9. C. C. Reyes-Aldasoro, I. Wilson, V. E. Prise, P. R. Barber, S. M. Ameer-Beg, B. Vojnovic, V. J. Cunningham, G. M. Tozer, Microcirculation 2008, 15, 65-79.
10. C. Kanthou, G. M. Tozer, Int. J. Exp. Path. 2009, 90, 284-294.
11. a) P. Hinnen, F. Eskens, Brit. J. Cancer 2007, 96, 1159-1165
12. b) W. J. van Heeckeren, S. Bhakta, J. Ortiz, J. Duerk, M. M. Cooney, A. Dowlati, K. McCrae, S. C. Remick, J. Clin. Onc. 2006, 24, 1485-1488.
13. J. M. Atkinson, C. S. Siller, J. H. Gill, Brit. J. Pharmacol. 2008, 153, 1344-1352.
14. L. M. Coussens, B. Fingleton, L. M. Matrisian, Science 2002, 295, 2387-2392.
15. a) J. Ueda, M. Kajita, N. Suenaga, K. Fujii, M. Seiki, Oncogene 2003, 22, 8716-8722
16. b) F. Sabeh, I. Ota, K. Holmbeck, H. Birkedal-Hansen, P. Soloway, M. Balbin, C. Lopez-Otin, S. Shapiro, M. Inada, S. Krane, E. Allen, D. Chung, S. J. Weiss, J. Cell Biol. 2004, 167, 769-781
17. c) L. Devy, L. L. Huang, L. Naa, N. Yanamandra, H. Pieters, N. Frans, E. Chang, Q. F. Tao, M. Vanhove, A. Lejeune, R. van Gool, D. J. Sexton, G. Kuang, D. Rank, S. Hogan, C. Pazmany, Y. L. Ma, S. Schoonbroodt, A. E. Nixon, R. C. Ladner, R. Hoet, P. Henderikx, C. TenHoor, S. A. Rabbani, M. L. Valentino, C. R. Wood, D. T. Dransfield, Cancer Res. 2009, 69, 1517-1526
18. d) M. M. Handsley, D. R. Edwards, Int. J. Cancer 2005, 115, 849-860.
19. R. Landry, P. M. Jacobs, R. Davis, M. Shenouda, W. K. Bolton, Am. J. Nephrol. 2005, 25, 400-410.
20. J. M. Atkinson, R. A. Falconer, D. R. Edwards, C. J. Pennington, C. S. Siller, S. D. Shnyder, M. C. Bibby, L. H. Patterson, P. M. Loadman, J. H. Gill, Cancer Res. 2010, 70, 6902-6912.
21. a) D. R. Elias, D. L. J. Thorek, A. K. Chen, J. Czupryna, A. Tsourkas, Cancer Biomarkers 2008, 4, 287-305; b)
22. H. Kobayashi, P. L. Choyke, Acc. Chem. Res. 2011, 44, 83-90; c)
23. J. Park, J. Yang, E.-K. Lim, E. Kim, J. Choi, J. K. Ryu, N. H. Kim, J.-S. Suh, J. I. Yook, Y.-M. Huh, S. Haam, Angew. Chem. Int. Ed. 2012, 51, 945-948.
24. T. Lammers, S. Aime, W. E. Hennink, G. Storm, F. Kiessling, Acc. Chem. Res. 2011, 44, 1029-1038.
25. A. J. L. Villaraza, A. Bumb, M. W. Brechbiel, Chem. Rev. 2010, 110, 2921-2959.
26. W. Li, S. Tutton, A. T. Vu, L. Pierchala, B. S. Y. Li, J. M. Lewis, P. V. Prasad, R. R. Edelman, J. Mag. Reson. Im. 2005, 21, 46-52.
27. T. Lammers, L. Y. Rizzo, G. Storm, F. Kiessling, Clin. Cancer Res. 2012, 18, 4889-4894.
28. K. J. Cho, X. Wang, S. M. Nie, Z. Chen, D. M. Shin, Clin. Cancer Res. 2008, 14, 1310-1316.
29. a) E. S. Olson, T. Jiang, T. A. Aguilera, Q. T. Nguyen, L. G. Ellies, M. Scadeng, R. Y. Tsien, Proc. Natl. Acad. Sci. USA 2010, 107, 4311-4316
30. b) Q. T. Nguyen, E. S. Olson, T. A. Aguilera, T. Jiang, M. Scadeng, L. G. Ellies, R. Y. Tsien, Proc. Natl. Acad. Sci. USA 2010, 107, 4317-4322.
31. D. Yoo, J. H. Lee, T. H. Shin, J. Cheon, Acc. Chem. Res. 2011, 44, 863-874
32. b) X. W. Ma, Y. L. Zhao, X. J. Liang, Accounts Chem. Res. 2011, 44, 1114-1122
33. c) F. M. Kievit, M. Q. Zhang, Acc. Chem. Res. 2011, 44, 853-862
34. d) H. Cabral, N. Nishiyama, K. Kataoka, Accounts Chem. Res. 2011, 44, 999-1008
35. e) J. V. Jokerst, S. S. Gambhir, Acc. Chem. Res. 2011, 44, 1050-1060
36. f) A. Fernandez-Fernandez, R. Manchanda, A. J. McGoron, Appl. Biochem. Biotechnol. 2011, 165, 1628-1651
37. g) M. E. Caldorera-Moore, W. B. Liechty, N. A. Peppas, Acc. Chem. Res. 2011, 44, 1061-1070
38. h) W. T. Al-Jamal, K. Kostarelos, Acc. Chem. Res. 2011, 44, 1094-1104.
39. a) M. J. Ernsting, W. D. Foltz, E. Undzys, T. Tagami, S. D. Li, Biomaterials 2012, 33, 3931-3941
40. b) M. Y. Liao, P. S. Lai, H. P. Yu, H. P. Lin, C. C. Huang, Chem. Commun. 2012, 48, 5319-5321.
41. C. Minelli, S. B. Lowe, M. M. Stevens, Small 2010, 6, 2336-2357.
42. a) V. S. Balakrishnan, M. Rao, A. T. Kausz, L. Brenner, B. J. G. Pereira, T. B. Frigo, J. M. Lewis, Eur. J. Clin. Invest. 2009, 39, 489-496; b)
43. E. A. Neuwelt, C. G. Varallyay, S. Manninger, D. Solymosi, M. Haluska, M. A. Hunt, G. Nesbit, A. Stevens, M. Jerosch-Herold, P. M. Jacobs, J. M. Hoffman, Neurosurgery 2007, 60, 601-611; c)
44. M. Lu, M. H. Cohen, D. Rieves, R. Pazdur, Am. J. Hematol. 2010, 85, 315-319.
45. L. Josephson, C. H. Tung, A. Moore, R. Weissleder, Bioconjugate Chem. 1999, 10, 186-191; b)
46. D. Högemann, L. Josephson, R. Weissleder, J. P. Basilion, Bioconjugate Chem. 2000, 11, 941-946.
47. R. F. Ziolo, E. P. Giannelis, B. A. Weinstein, M. P. Ohoro, B. N. Ganguly, V. Mehrotra, M. W. Russell, D. R. Huffman, Science 1992, 257, 219-223.
48. a) L. Varticovski, M. G. Hollingshead, A. I. Robles, X. L. Wu, J. Cherry, D. J. Munroe, L. Lukes, M. R. Anver, J. P. Carter, S. D. Borgel, H. Stotler, C. A. Bonomi, N. P. Nunez, S. D. Hursting, W. H. Qiao, C. X. X. Deng, J. E. Green, K. W. Hunter, G. Merlino, P. S. Steeg, L. M. Wakefield, J. C. Barrett, Clin. Cancer Res. 2007, 13, 2168-2177; b)
49. M. C. Bibby, Eur. J. Cancer 2004, 40, 852-857; c)
50. T. H. Kuo, T. Kubota, M. Watanabe, T. Furukawa, S. Kase, H. Tanino, Y. Saikawa, K. Ishibiki, M. Kitajima, R. M. Hoffman, Anticancer Res. 1993, 13, 627-630.
51. a) C. T. Guy, R. D. Cardiff, W. J. Muller, Mol. Cell. Biol. 1992, 12, 954-961; b)
52. E. Y. Lin, J. G. Jones, P. Li, U. Y. Zhu, K. D. Whitney, W. J. Muller, J. W. Pollard, Am. J. Pathol. 2003, 163, 2113-2126.